NORDION INC | 5,563 Euro | -0,007 -0,13 % | |
| WKN: A1C8AE ISIN: CA65563C1059 Ticker-Symbol: XMD | Frankfurt | 21.05.13 | 08:01 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 16.05. | Nordion, Navidea sign contract manufacturing agreement | - | Pharma Bus Review | |
| 15.05. | Nordion Inc: Nordion, Navidea sign contract manufacturing deal | 1 | Stockwatch | |
| 25.03. | Nordion, Dr. Reddy's Laboratories settle claims | 1 | Pharma Bus Review | |
| 06.03. | Nordion Inc. - Shareholder/Analyst Call | - | Seeking Alpha | |
| 06.03. | Nordion Management Discusses Q1 2013 Results - Earnings Call Transcript | 1 | Seeking Alpha | |
| 06.03. | Medical isotope maker Nordion's loss narrows | - | Reuters.com | |
| 28.01. | Why Nordion Shares Popped | - | Motley Fool | |
| 28.01. | UPDATE 3-Medical isotope maker Nordion explores alternatives | 1 | Reuters.com | |
| 28.01. | UPDATE 1-Medical isotope maker Nordion explores strategic alternatives | - | Reuters.com | |
| 28.01. | Nordion explores strategic alternatives | - | Reuters.com | |
| 22.01. | Nordion Continues To Prepare Investors For A New-Look Company | 1 | Seeking Alpha | |
| 12.12. | Nordion (NDZ) to Postpone Q4 Results Call on Litigation, Credit Facility Discussions | - | StreetInsider.com | |
| 05.12. | Canada's Nordion says AECL puts arbitration costs at $46m | - | Mining Weekly | |
| 05.12. | Canada's Nordion says AECL puts arbitration costs at $46 million | - | Reuters.com | |
| 04.12. | Nordion (NDZ) Update on MAPLE Arbitration Costs | - | StreetInsider.com | |
| 29.10. | Nordion Restructures Russian Mo-99 Supply Relationship | 46 | Business Wire | |
| Nordion Inc. (TSX: NDN) (NYSE: NDZ) announced today that it has been
granted special permission by The Open Joint Stock Company "Isotope"
(Isotope), the authorized subsidiary... Mehr lesen zu: Nordion Restructures Russian Mo-99 Supply Relationship | ||||
| 27.08. | Nordion Provides Update on Timing of AECL MAPLE Arbitration Decision | 20 | PR Newswire | |
| OTTAWA, Aug. 27, 2012 /PRNewswire/ - Nordion Inc. (TSX: NDN) (NYSE: NDZ), a
leading provider of products and services for the prevention, diagnosis
and treatment of disease, today released an update... Mehr lesen zu: Nordion Provides Update on Timing of AECL MAPLE Arbitration Decision | ||||
| 08.08. | Nordion Statement on Voluntary Disclosure | 24 | PR Newswire | |
| OTTAWA, Aug. 8, 2012 /PRNewswire/ - Nordion Inc. (TSX: NDN) (NYSE: NDZ), a
leading provider of products and services for the prevention, diagnosis
and treatment of disease, today disclosed that... Mehr lesen zu: Nordion Statement on Voluntary Disclosure | ||||
| 29.06. | Nordion Provides Update on AECL MAPLE Arbitration | 23 | PR Newswire | |
| OTTAWA, June 29, 2012 /PRNewswire/ - Nordion Inc. (TSX: NDN) (NYSE: NDZ), a
leading provider of products and services for the prevention, diagnosis
and treatment of disease, today released an update... Mehr lesen zu: Nordion Provides Update on AECL MAPLE Arbitration | ||||
| 13.06. | XFRA DIVIDEND INFORMATION - 14.06.2012 - 1 | 180 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 13.06.2012 CUM DIVIDENDE UND AM 14.06.2012
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 13.06.2012. THE
EX-DIVIDEND DAY WILL BE 14.06.2012.
... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 14.06.2012 - 1 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| QIAGEN | 14,48 | +0,14 % | Qiagen und SYGNIS Pharma schließen Lizenzvertrag |
| BB BIOTECH | 97,93 | -0,07 % | XFRA H MISTRADE ANTRAG IN ISIN CH0038389992 WURDE STATTGEGEBEN |
| MORPHOSYS | 34,905 | -0,98 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| EVOTEC | 2,798 | -0,43 % | Evotec: Kurs der Aktie hat weiteres Potenzial |
| AFFYMETRIX | 2,849 | -1,96 % | Affymetrix Names Gavin Wood EVP & CFO |
